Cufsniff BR Plus Syrup contains Bromhexine 4 mg, Guaifenesin 50 mg, Menthol 0.5 mg, and Terbutaline 1.25 mg per 5 ml, a comprehensive respiratory combination therapy formulated to address productive cough associated with mucus retention and bronchial constriction. Bromhexine reduces mucus viscosity, enabling easier clearance from the airways.
Guaifenesin acts as an expectorant, increasing respiratory tract fluid secretion and facilitating effective expectoration, while Menthol provides a soothing and cooling effect that relieves throat irritation and cough discomfort. Terbutaline, a selective β2-agonist, relaxes bronchial smooth muscles to improve airflow.
Clinically, this formulation is indicated for acute and chronic bronchitis, productive cough, bronchospasm, and other lower respiratory tract infections where mucus accumulation and airway narrowing coexist. The synergistic action ensures rapid symptom relief and improved respiratory comfort.
The syrup formulation allows accurate dosing, fast absorption, and excellent patient compliance, making it suitable for hospitals, general practice, pediatric care, and retail pharmacies. Cufsniff BR Plus Syrup supports effective cough control, easier breathing, and faster recovery under medical supervision.